Aethlon Medical Market Cap 2006-2019 | AEMD

Aethlon Medical market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Aethlon Medical market cap as of April 08, 2020 is $0.01B.
Sector Industry Market Cap Revenue
Medical Medical - Health Maintenance Organizations $0.012B $0.000B
Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development of therapeutic devices that treat acute viral conditions, chronic viral diseases and pathogens targeted as potential biological warfare agents. The Hemopurifier(R) combines the established scientific principles of affinity chromatography and hemodialysis as a means to mimic the immune system's response of clearing viruses and toxins from the blood before cell and organ infection can occur. The Hemopurifier(R) cannot cure viral conditions but can prevent virus and toxins from infecting unaffected tissues and cells. The company has completed pre-clinical blood testing of the Hemopurifier(R) to treat HIV and Hepatitis-C, and have completed human safety trials on Hepatitis-C infected patients in India.
Stock Name Country Market Cap PE Ratio
UnitedHealth Group (UNH) United States $235.284B 16.42
Anthem (ANTM) United States $56.491B 11.54
Humana (HUM) United States $42.286B 17.94
Centene (CNC) United States $35.297B 13.61
Molina Healthcare (MOH) United States $8.525B 12.00
Select Medical Holdings (SEM) United States $1.845B 11.08
Magellan Health (MGLN) United States $1.206B 13.09
Triple-S Management (GTS) United States $0.320B 5.21
Joint (JYNT) United States $0.142B 44.44